Product Specification| Host | Human | | Antigen | IL-17A | | Synonyms | Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8 (CTLA-8), CTLA8, IL17 | | Accession | Q16552 | | Clone Number | S-SC008 | | Antibody Type | Recombinant mAb | | Isotype | IgG4,k | | Application | Blocking of IL-17A signaling Functional assays | | Purification | Protein A | | Concentration | 2 mg/ml | | Endotoxin | <1EU/mg | | Conjugation | Unconjugated | | Physical Appearance | Liquid | | Storage Buffer | PBS pH7.4, containing no preservative | | Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution| application | dilution | species | | ELISA | 1.221-5000 ng/ml | |
BackgroundIxekizumab is an injectable medication for the treatment of autoimmune diseases. It is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation. bio-equip.cn AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
|
中文
